(Q38382991)

2 September 2017

1 reference

title

Targeting liver X receptors in cancer therapeutics (English)

1 reference

2 September 2017

Chin-Yo Lin

1

1 reference

2 September 2017

Jan-Åke Gustafsson

series ordinal

2

1 reference

2 September 2017

language of work or name

English

0 references

publication date

19 March 2015

1 reference

2 September 2017

Nature Reviews Cancer

1 reference

2 September 2017

15

1 reference

2 September 2017

216-224

1 reference

2 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc3912

2 September 2017

0 references

cites work

Principles for modulation of the nuclear receptor superfamily

1 reference

G protein-coupled receptors: novel targets for drug discovery in cancer

31 March 2020

1 reference

Estrogen receptor alpha in human breast cancer: occurrence and significance

31 March 2020

1 reference

Selective estrogen receptor modulation: concept and consequences in cancer

31 March 2020

1 reference

Antiandrogens in prostate cancer endocrine therapy

31 March 2020

1 reference

Domain structure of human glucocorticoid receptor and its relationship to the v-erb-A oncogene product.

31 March 2020

1 reference

Ubiquitous receptor: a receptor that modulates gene activation by retinoic acid and thyroid hormone receptors

31 March 2020

1 reference

NER, a new member of the gene family encoding the human steroid hormone nuclear receptor

31 March 2020

1 reference

A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily

31 March 2020

1 reference

OR-1, a member of the nuclear receptor superfamily that interacts with the 9-cis-retinoic acid receptor

31 March 2020

1 reference

LXR, a nuclear receptor that defines a distinct retinoid response pathway

31 March 2020

1 reference

A unified nomenclature system for the nuclear receptor superfamily

31 March 2020

1 reference

Structure of the retinoid X receptor α-liver X receptor β (RXRα-LXRβ) heterodimer on DNA

31 March 2020

1 reference

An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha

31 March 2020

1 reference

Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta

31 March 2020

1 reference

Plant sterols and stanols: effects on mixed micellar composition and LXR (target gene) activation

31 March 2020

1 reference

Identification of 5α, 6α-epoxycholesterol as a novel modulator of liver X receptor activity

31 March 2020

1 reference

Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR.

31 March 2020

1 reference

Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements

31 March 2020

1 reference

Riccardin C: a natural product that functions as a liver X receptor (LXR)alpha agonist and an LXRbeta antagonist

31 March 2020

1 reference

Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARalpha, PPARgamma and LXRalpha

31 March 2020

1 reference

Role of LXRs in control of lipogenesis

31 March 2020

1 reference

T0901317 is a dual LXR/FXR agonist

31 March 2020

1 reference

T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR

31 March 2020

1 reference

Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines

31 March 2020

1 reference

Synthetic LXR ligand inhibits the development of atherosclerosis in mice

31 March 2020

1 reference

Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist

31 March 2020

1 reference

Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor

31 March 2020

1 reference

Selective liver X receptor modulators (SLiMs): what use in human health?

31 March 2020

1 reference

Action mechanisms of Liver X Receptors.

31 March 2020

1 reference

Liver X receptor biology and pharmacology: new pathways, challenges and opportunities.

31 March 2020

1 reference

Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor α in mouse liver reveals extensive sharing of binding sites

31 March 2020

1 reference

Genome-wide analysis of estrogen receptor binding sites

31 March 2020

1 reference

Whole-genome cartography of estrogen receptor alpha binding sites

31 March 2020

1 reference

Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells

31 March 2020

1 reference

Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFN-gamma-stimulated brain astrocytes.

31 March 2020

1 reference

Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha

31 March 2020

1 reference

Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue

31 March 2020

1 reference

LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function

31 March 2020

1 reference

Separate and overlapping metabolic functions of LXRalpha and LXRbeta in C57Bl/6 female mice

31 March 2020

1 reference

Both liver-X receptor (LXR) isoforms control energy expenditure by regulating brown adipose tissue activity

31 March 2020

1 reference

Pancreatic exocrine insufficiency in LXRbeta-/- mice is associated with a reduction in aquaporin-1 expression

31 March 2020

1 reference

Liver X receptor beta (LXRbeta): a link between beta-sitosterol and amyotrophic lateral sclerosis-Parkinson's dementia

31 March 2020

1 reference

Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration

31 March 2020

1 reference

LXR activation reduces proinflammatory cytokine expression in human CD4-positive lymphocytes

31 March 2020

1 reference

LXR activation inhibits chemokine-induced CD4-positive lymphocyte migration.

31 March 2020

1 reference

Liver-X-receptor activator prevents homocysteine-induced production of IgG antibodies from murine B lymphocytes via the ROS-NF-kappaB pathway

31 March 2020

1 reference

Liver X receptors control IgE expression in B cells.

31 March 2020

1 reference

LIVER X RECEPTOR IS A KEY REGULATOR OF CYTOKINE RELEASE IN HUMAN MONOCYTES

31 March 2020

1 reference

Liver X receptors as integrators of metabolic and inflammatory signaling

31 March 2020

1 reference

LXR-mediated inhibition of CD4+ T helper cells

31 March 2020

1 reference

Liver X receptor activation decreases the severity of experimental autoimmune encephalomyelitis.

31 March 2020

1 reference

LXR-dependent gene expression is important for macrophage survival and the innate immune response

31 March 2020

1 reference

Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis

31 March 2020

1 reference

Novel role for the liver X nuclear receptor in the suppression of lung inflammatory responses

31 March 2020

1 reference

Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense.

31 March 2020

1 reference

Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology.

31 March 2020

1 reference

Role of PPAR, LXR, and PXR in epidermal homeostasis and inflammation.

31 March 2020

1 reference

LXR modulation blocks prostaglandin E2 production and matrix degradation in cartilage and alleviates pain in a rat osteoarthritis model

31 March 2020

1 reference

Simultaneous activation of the liver X receptors (LXR and LXR ) drives murine collagen-induced arthritis disease pathology

31 March 2020

1 reference

Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors

31 March 2020

1 reference

The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease

31 March 2020

1 reference

31 March 2020

LIPID CONTENT OF TUMORS.

1 reference

Epoxycholesterols in secretions and tissues of normal, benign, and cancerous human prostate glands

31 March 2020

1 reference

Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence

31 March 2020

1 reference

Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells

31 March 2020

1 reference

Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells

31 March 2020

1 reference

The oxysterol receptor LXR inhibits proliferation of human breast cancer cells

31 March 2020

1 reference

Liver X receptors interfere with cytokine-induced proliferation and cell survival in normal and leukemic lymphocytes.

31 March 2020

1 reference

Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism.

31 March 2020

1 reference

The oxysterol receptors LXRα and LXRβ suppress proliferation in the colon.

31 March 2020

1 reference

Liver X receptors inhibit proliferation of human colorectal cancer cells and growth of intestinal tumors in mice

31 March 2020

1 reference

Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells.

31 March 2020

1 reference

Activation of liver X receptors inhibits hedgehog signaling, clonogenic growth, and self-renewal in multiple myeloma

31 March 2020

1 reference

Liver X receptor activation induces apoptosis of melanoma cell through caspase pathway

31 March 2020

1 reference

Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation

31 March 2020

1 reference

Androgenic suppression of ATP-binding cassette transporter A1 expression in LNCaP human prostate cancer cells

31 March 2020

1 reference

Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells.

31 March 2020

1 reference

Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity

31 March 2020

1 reference

LXR agonist regulates the carcinogenesis of PCa via the SOCS3 pathway

31 March 2020

1 reference

Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3.

31 March 2020

1 reference

An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway

31 March 2020

1 reference

Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis.

31 March 2020

1 reference

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models

31 March 2020

1 reference

A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancer

31 March 2020

1 reference

Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer

31 March 2020

1 reference

Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors

31 March 2020

1 reference

The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells

31 March 2020

1 reference

Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor

31 March 2020

1 reference

Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses

31 March 2020

1 reference

Identification of interferon-γ as a new molecular target of liver X receptor

31 March 2020

1 reference

Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2.

31 March 2020

1 reference

Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants.

31 March 2020

1 reference

Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo

31 March 2020

1 reference

Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor.

31 March 2020

1 reference

12 December 2020

Separation of the hormone- and DNA-binding sites of the hepatic glucocorticoid receptor by means of proteolysis

1 reference

12 December 2020

Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors

1 reference

12 December 2020

LXR agonists and ABCG1-dependent cholesterol efflux in MCF-7 breast cancer cells: relation to proliferation and apoptosis.

1 reference

12 December 2020

Androgen deprivation by activating the liver X receptor

1 reference

12 December 2020

Macrophage apolipoprotein E and proliferation of MCF-7 breast cancer cells: role of LXR.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC3912

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference